Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll DNA methylation in hepatocellular carcinoma Tischoff I; Tannapfe AWorld J Gastroenterol 2008[Mar]; 14 (11): 1741-8As for many other tumors, development of hepatocellular carcinoma (HCC) must be understood as a multistep process with accumulation of genetic and epigenetic alterations in regulatory genes, leading to activation of oncogenes and inactivation or loss of tumor suppressor genes (TSG). In the last decades, in addition to genetic alterations, epigenetic inactivation of (tumor suppressor) genes by promoter hypermethylation has been recognized as an important and alternative mechanism in tumorigenesis. In HCC, aberrant methylation of promoter sequences occurs not only in advanced tumors, it has been also observed in premalignant conditions just as chronic viral hepatitis B or C and cirrhotic liver. This review discusses the epigenetic alterations in hepatocellular carcinoma focusing DNA methylation.|*DNA Methylation[MESH]|*Gene Expression Regulation, Neoplastic[MESH]|Carcinoma, Hepatocellular/*genetics/metabolism/pathology[MESH]|Cell Transformation, Neoplastic/genetics/metabolism[MESH]|Chromatin Assembly and Disassembly[MESH]|DNA, Neoplasm/*metabolism[MESH]|Epigenesis, Genetic[MESH]|Histones/metabolism[MESH]|Humans[MESH]|Liver Neoplasms/*genetics/metabolism/pathology[MESH]|Promoter Regions, Genetic[MESH] |